Nuzenio

Phase Iia

Phase Iia news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Rare lung disease drug CS014 heads into FDA-guided study to speed Phase II - Stock TitanStock Titan · Sun, 09 Aug 2026 12:36:06 GMTNeuroThera Launches Phase IIb Trial at Yale for Novel Tourette Treatment - citybuzz -citybuzz - · Thu, 06 Aug 2026 00:24:05 GMTSciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock TitanStock Titan · Wed, 05 Aug 2026 13:00:51 GMTSciSparc’s NeuroThera Opens Yale Site for Phase IIb SCI-110 Tourette Syndrome Trial - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 12:30:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMTNeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome - TheNewswireTheNewswire · Wed, 05 Aug 2026 12:09:29 GMTEnrolment concludes in 4Moving Biotech’s Phase IIa trial of 4P004 - YahooYahoo · Tue, 04 Aug 2026 10:36:02 GMTUmecrine Cognition includes final patient in Phase Ib/IIa study - BiostockBiostock · Mon, 03 Aug 2026 07:00:00 GMT

Timeline

Sun, 09 Aug 2026 12:36:06 GMTRare lung disease drug CS014 heads into FDA-guided study to speed Phase II - Stock Titan
Thu, 06 Aug 2026 00:24:05 GMTNeuroThera Launches Phase IIb Trial at Yale for Novel Tourette Treatment - citybuzz -
Wed, 05 Aug 2026 13:00:51 GMTSciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock Titan
Wed, 05 Aug 2026 12:30:00 GMTSciSparc’s NeuroThera Opens Yale Site for Phase IIb SCI-110 Tourette Syndrome Trial - Quiver Quantitative
Wed, 05 Aug 2026 12:22:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock Titan
Wed, 05 Aug 2026 12:09:29 GMTNeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome - TheNewswire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Phase Iia.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.